Cosmos HealthCOSM -10.91%29 Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus rates COSM with a GF Score™ of 29/100 and a GF Value™ of $0.36 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 91 Medical Distribution companies, Cosmos Health ranks worse than 1098900% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Cosmos Health's
Operating Income
for the
three
months ended in Mar. 2026 was $-2.18 Mil. Cosmos Health's Interest Expense for the
three
months ended in Mar. 2026 was $-0.81 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Cosmos Health's Interest Coverage or its related term are showing as below:
COSM's Interest Coverage is not ranked *
in the Medical Distribution industry.
Industry Median: 6.92 * Ranked among companies with meaningful Interest Coverage only.
Cosmos Health (NAS:COSM) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Cosmos Health Interest Coverage Related Terms
Cosmos Health Interest Coverage Historical Data
* Premium members only.
The historical data trend for Cosmos Health's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
COSM vs HKPD, VNOV, SNYR: Interest Coverage Comparison
For the Medical Distribution subindustry, Cosmos Health's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmos Health Interest Coverage vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cosmos Health's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Cosmos Health's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Cosmos Health did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Cosmos Health (COSM) has a Interest Coverage of 0 (At Loss) as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Cosmos Health and its competitors. According to the industry distribution chart, Cosmos Health ranks #999999 out of 91 companies in the Medical Distribution industry.
Is Cosmos Health's Interest Coverage too high?
Cosmos Health's current Interest Coverage is 0 (At Loss). Based on the distribution chart, Cosmos Health ranks #999999 out of 91 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Cosmos Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's Interest Coverage compare to HKPD and VNOV?
According to the Medical Distribution industry distribution chart, Cosmos Health ranks #999999 out of 91 companies for Interest Coverage. This places Cosmos Health in the lower half of its industry. The industry median Interest Coverage is 6.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Distribution company?
The median Interest Coverage among Medical Distribution companies is 6.92, based on 91 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Cosmos Health and its competitors. For the Medical Distribution industry, the median Interest Coverage is 6.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmos Health's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Possible Value Trap. The stock's GF Value™ is $0.36, compared to a current price of $0.19 — trading 48.5% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Cosmos Health's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Cosmos Health (COSM), the current Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmos Health (COSM) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued.
The current stock price of $0.19 is trading 48.5% below its estimated GF Value™ of $0.36.
GuruFocus considers Cosmos Health to be Possible Value Trap.
Key valuation signals for COSM:
Interest Coverage: 0 (At Loss)
GF Value™: $0.36 vs. price of $0.19 (48.5% below fair value)
No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
29GF Score
Get the complete analysis for COSM
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COSM has been successfully added to your 
